Vaxxas’ proprietary high-density microarray patch (HD-MAP) technology is currently being evaluated in a phase 1 clinical study of the first needle-free COVID-19 vaccine, having demonstrated ...

Oct. 17, 2024 — With viral outbreaks spreading more quickly, faster responses and quicker development of new vaccines has become crucial. However, production of the mRNA used in vaccines is ...

Inactivated vaccines, also called killed vaccines, are made from a protein or other small pieces taken from a virus or bacteria. They use this component to stimulate the immune system to protect the ...

India's top vaccine maker has bought a 50% stake in a major Bollywood production company known for making popular films. Adar ...

This license enables Vaxxas to prepare for a clinical trial of the first Respiratory Syncytial Virus (RSV) vaccine delivered to the skin using Vaxxas’ novel high-density microarray patch (HD-MAP).

Six San Francisco public transport employees who were fired for refusing to get COVID-19 vaccines have been awarded more than $1 million each. The Bay Area Rapid Transit (BART) employees filed a ...

Pneumococcal vaccines are the most effective way to protect yourself or your child against pneumococcal disease, including ear infections, pneumonia (lung infection), blood infection, and meningitis ...

The measles-rubella microarray patch is a small sticker that could address some pretty large problems. Measles-containing vaccines are 97% effective at preventing the spread of what is considered ...